Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.587ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.397ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.399ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.337ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.539ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.392ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.426ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.399ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.1.337ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.539ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
C.35ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.177.54ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.164ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
KY.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JN.2.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.1.392ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BG.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
JF.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.572ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used